Related Experiment Video

Updated: Aug 15, 2026

Simultaneous Measurements of Intracellular Calcium and Membrane Potential in Freshly Isolated and Intact Mouse Cerebral Endothelium
09:45

Simultaneous Measurements of Intracellular Calcium and Membrane Potential in Freshly Isolated and Intact Mouse Cerebral Endothelium

Published on: January 20, 2019

[Calcium antagonists and endothelial function]

Osamu Yasuda1, Hidenobu Kawamoto, Toyohiko Yokoi

  • 1Department of Geriatric Medicine, Osaka University Medical School.

Clinical Calcium
|October 4, 2005
PubMed

Insights

Calcium antagonists like nifedipine improve endothelial function by boosting nitric oxide (NO) production. This mechanism involves stimulating superoxide dismutase (SOD) expression, reducing oxidative stress in atherosclerosis.

Area of Science:

  • Cardiovascular Medicine
  • Endothelial Biology
  • Pharmacology

Context:

  • Endothelial dysfunction is an early indicator of atherosclerosis.
  • Risk factors like hypertension, hyperlipidemia, and diabetes mellitus are linked to early endothelial dysfunction.
  • Cardiovascular complications often follow endothelial dysfunction.

Purpose:

  • To explore the mechanisms by which calcium antagonists improve endothelial function.
  • To investigate the role of nifedipine in mitigating endothelial dysfunction.
  • To elucidate the signaling pathways involved in enhanced nitric oxide (NO) production.

Summary:

  • Calcium antagonists protect the endothelium via hypotensive action and by stimulating NO production.
  • Nifedipine may enhance endothelial NO production by stimulating SOD expression in endothelial cells.
  • This effect is potentially mediated by increased VEGF expression in vascular smooth muscle cells, reducing oxidative stress.

Impact:

  • Provides insight into the therapeutic potential of calcium antagonists beyond blood pressure control.
  • Highlights a novel mechanism for improving endothelial function in atherosclerosis.
  • Suggests a strategy for preventing cardiovascular complications by targeting oxidative stress and NO pathways.

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 200007:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...